• Zum Hauptinhalt springen
  • Zum Footer springen

IPEK

  • ABOUT US
    • INSTITUTE DIRECTOR
    • ORGANISATION
    • PEOPLE A-Z
    • T&H EDITORIAL OFFICE
    • AUGUTST - LENZ
    • FREY - WERLE
    • VISIT US
    • CONTACT US
  • LABS
    • ATZLER LUTGENS LAB
    • BARTELT LAB
    • DÖRING LAB
    • DUCHÊNE MEGENS LAB
    • HUNDELSHAUSEN LAB
    • MOHANTA HABENICHT LAB
    • RIES LAB
    • SANTOVITO LAB
    • SCHOBER LAB
    • STEFFENS LAB
    • WEBER LAB
  • TECHNOLOGY
    • MICROSCOPY
    • TRANSGENIC & GENE TARGETING
    • CELL SORTING & FLOW CYTOMETRY
    • (EPI)TRANSCRIPTOMIC CORE UNIT
  • PUBLICATIONS
  • FUNDING
  • EDUCATION
    • TEACHING
    • GRADUATE SCHOOL
  • NEWS | REPORTS
    • NEWS
    • EVENTS
    • REPORTS
    • OPEN POSITIONS
  1. HOME
  2. PUBLICATIONS
  3. Publications reverse format

Publications reverse format

Highlights

Open Access Nature Cardiocascular Research https://www.nature.com/articles/s44161-023-00413-9

New signalling pathway uncovered, shedding fresh light on atherosclerosis

NATURE CARDIOVASCULAR RESEARCH 2024 ➤ IPEK scientists from the Weber and Döring Labs have found new mechanisms involved in the development of inflammatory cardiovascular diseases.

Weber Lab | IPEK

Atherosclerosis: RNA fragment creates prospect for new therapies

SCIENCE TRANSLATIONAL MEDICINE 2023  ➤ IPEK researchers have demonstrated for the first time what role a specific microRNA plays in atherosclerosis – and how it manages to intervene in this signaling…

T cells and atherosclerosis: the good, the bad, and the unknown

NATURE CARDIOVASCULAR RESEARCH 2023  ➤ IPEK scientists describe that atherosclerosis leads to disorders of the immune system, similar to those in known autoimmune diseases. Pairing of single-cell RNA…

2022
National Institutes of Allergy and Infectious Diseases, National Institutes of Health

Atherosclerosis: how the body controls the activity of B cells

NATURE CARDIOVASCULAR RESEARCH 2022  ➤ IPEK scientists have identified a protein that is involved in the regulation of immune cells and can curb the development of atherosclerosis.

How antibodies get it wrong

CELL STEM CELL 2022 ➤  IPEK scientists alert to the wrong use of antibodies in scientific publications. In their recent work, they refute a specific study on localization of immune receptor ACKR1.

@LMU

Atherosclerosis: How diseased blood vessels communicate with the brain

NATURE  2022 ➤ IPEK scientists have been able to demonstrate for the first time that nerve signals are exchanged between arteries and the brain in atherosclerosis.

Vectormanzone | Vecteezy.com

Arterial thromboses: innovative treatment approach

BlOOD 2022 ➤ IPEK scientists have shown in an animal model that the CXCL12 messenger could be suitable as a target structure for the treatment of blood-clotting disorders

2021
LMU Klinikum

BTK inhibitors against vaccine-related thrombotic complications

NEJM 2021 ➤ IPEK scientists propose treatment for rare, life-threatening complication from Astra-Zeneca vaccine.

Chuttersnap | Unsplash

Why is the risk of heart attack higher early in the day

CIRCULATION 2021 ➤ In the journal Circulation, a team led by IPEK scientists Maliheh Nazari-Jahantigh and Andreas Schober provides an answer.

Atherosclerosis and the immune system

NATURE  COMMUNICATIONS 2021 ➤ IPEK scientist have uncovered how signal proteins of the immune system regulate the development of atherosclerosis.

2020
 Dr. Carlos Silvestre-Roig @IPEK

Reduce heart attack risk after infections

CIRCULATION 2020 ➤ After an infection, the risk of a heart attack in cardiovascular risk patients increases up to twenty times. IPEK scientists have found that the immune cells are involved in this…

How a miRNA binds and inhibits Caspase-3 to confer vascular integrity

SCIENCE TRANSLATIONAL MEDICINE 2020  ➤ IPEK scientists have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of…

All Publications

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005

CRC1123

Munich Heart Alliance

TRR 267

SyNergy

CNATM

CONTACT US

Institute for Cardiovascular Prevention (IPEK)

Institute Director: Christian Weber

Pettenkoferstraße 9
80336 München
0049 (0)89 4400-54351 0049 (0)89 4400-54298

 ipek.office[at]med.lmu.de

QUICK LINKS

  • RESEARCH LABS
  • A-Z PEOPLE
  • DOWNLOADS
  • OPEN POSITIONS
  • LMU HOSPITAL
  • LMU UNIVERSITY

Editor login
Imprint | Data-Safety